The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 21, 2025
Filed:
Jun. 19, 2020
Applicant:
Celgene Quanticel Research, Inc., San Diego, CA (US);
Inventors:
C L Beach, Lee's Summit, MO (US);
Shelonitda Rose, Branchburg, NJ (US);
Diana R. Dunshee, Alamo, CA (US);
Daniel E. Lopes De Menezes, Berkeley, CA (US);
Kyle Macbeth, Santa Rosa, CA (US);
Yumin Dai, Danville, CA (US);
Jessica Jang, New York, NY (US);
Mark Frattini, Ridgewood, NJ (US);
Assignee:
Celgene Quanticel Research, Inc., San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/706 (2006.01); A61K 31/407 (2006.01); A61K 31/497 (2006.01); A61K 31/501 (2006.01); A61K 31/513 (2006.01); A61K 31/553 (2006.01); A61K 31/635 (2006.01); A61P 35/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/706 (2013.01); A61K 31/407 (2013.01); A61K 31/497 (2013.01); A61K 31/501 (2013.01); A61K 31/513 (2013.01); A61K 31/553 (2013.01); A61K 31/635 (2013.01); A61P 35/02 (2018.01);
Abstract
Provided herein are methods for using 5-azacytidine in combination with additional agents to treat diseases and disorders including AML.
Beach, C. (2025). Azacitidine in combination with venetoclax, gilteritinib, midostaurin or other compounds for treating leukemia or myelodysplastic syndrome (U.S. Patent No. 12447171). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12447171
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile